| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |